Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AMGEN INCAMGN · Entity 2832 | Director | August 07, 2026 | August 11, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AMGEN INC
Report date August 07, 2026 · Filed August 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 5,876.1633 |
Reported balance
After 2026-08-07 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-08-07 · Grant · Acquired 63.8764 · Balance 5,876.1633 F1: These shares include 377 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares include 377 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 07, 2026 Filed Aug 11, 2026 00:20 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 63.8764 | $0.00 | $0.00 |
DisclosureSEC source: 0000318154-26-000131 · form4.xml · nonDerivative · entry 1 Drake Michael V · CIK 0001938942 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,876.1633 F1 · balance_after: These shares include 377 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| May 19, 2026 Filed May 21, 2026 22:56 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 665 | $0.00 | $0.00 |
DisclosureSEC source: 0000318154-26-000099 · form4.xml · nonDerivative · entry 1 Drake Michael V · CIK 0001938942 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,774.2869 F1 · balance_after: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case payment will occur according to the elected deferral schedule. F2 · balance_after: These shares include 339 DEs granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| May 05, 2026 Filed May 8, 2026 00:36 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 79.6444 | $0.00 | $0.00 |
DisclosureSEC source: 0000318154-26-000069 · form4.xml · nonDerivative · entry 1 Drake Michael V · CIK 0001938942 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,109.2869 F1 · balance_after: These shares include 339 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| November 07, 2025 Filed Nov 13, 2025 00:31 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 218.6134 | $0.00 | $0.00 |
DisclosureSEC source: 0000318154-25-000077 · form4.xml · nonDerivative · entry 1 Drake Michael V · CIK 0001938942 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,958.6425 F1 · balance_after: These shares include 268 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred Restricted Stock Units and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount. Read SEC document |
| August 08, 2025 Filed Aug 12, 2025 23:24 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 121.4308 | $0.00 | $0.00 |
DisclosureSEC source: 0000318154-25-000060 · form4.xml · nonDerivative · entry 1 Drake Michael V · CIK 0001938942 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,699.0291 F1 · balance_after: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended (the Director Program), under the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule. F2 · balance_after: These shares include 227 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred Restricted Stock Units and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount. Read SEC document |
| May 23, 2025 Filed May 29, 2025 00:57 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 809 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-015849 · form4.xml · nonDerivative · entry 1 Drake Michael V · CIK 0001938942 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,546.5983 F1 · balance_after: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended (the Director Program), under the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule. F2 · balance_after: These shares include 196 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred Restricted Stock Units and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount. Read SEC document |
| May 06, 2025 Filed May 8, 2025 23:59 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 129.4187 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-013768 · form4.xml · nonDerivative · entry 1 Drake Michael V · CIK 0001938942 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,737.5983 F1 · balance_after: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended (the Director Program), under the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule. F2 · balance_after: These shares include 196 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred Restricted Stock Units and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount. Read SEC document |
| November 04, 2024 Filed Nov 7, 2024 00:37 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 220.8829 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-026622 · form4.xml · nonDerivative · entry 1 Drake Michael V · CIK 0001938942 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,552.1796 F1 · balance_after: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case payment will occur according to the elected deferral schedule F2 · balance_after: These shares include 140 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred Restricted Stock Units and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount. Read SEC document |
| August 09, 2024 Filed Aug 13, 2024 21:41 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 108.5305 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-022106 · form4.xml · nonDerivative · entry 1 Drake Michael V · CIK 0001938942 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,307.2967 F1 · balance_after: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case payment will occur according to the elected deferral schedule F2 · balance_after: These shares include 116 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred Restricted Stock Units and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 23:24 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 719 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-017806 · form4.xml · nonDerivative · entry 1 Drake Michael V · CIK 0001938942 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,174.7662 F1 · balance_after: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case payment will occur according to the elected deferral schedule. F2 · balance_after: These shares include 92 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred Restricted Stock Units and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount. Read SEC document |
| May 07, 2024 Filed May 8, 2024 23:56 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 116.5501 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-014684 · form4.xml · nonDerivative · entry 1 Drake Michael V · CIK 0001938942 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,455.7662 F1 · balance_after: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSU's may be deferred by the director, in which case payment will occur according to the elected deferral schedule. F2 · balance_after: These shares include 92 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred Restricted Stock Units and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount. Read SEC document |
| November 03, 2023 Filed Nov 8, 2023 01:06 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 240.8656 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-026972 · form4.xml · nonDerivative · entry 1 Drake Michael V · CIK 0001938942 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,301.2161 F1 · balance_after: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSU's may be deferred by the director, in which case payment will occur according to the elected deferral schedule. F2 · balance_after: These shares include 54 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred Restricted Stock Units and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount. Read SEC document |
| August 08, 2023 Filed Aug 11, 2023 00:55 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 124.6166 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-022309 · form4.xml · nonDerivative · entry 1 Drake Michael V · CIK 0001938942 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,024.3505 F1 · balance_after: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSU's may be deferred by the director, in which case payment will occur according to the elected deferral schedule. F2 · balance_after: These shares include 18 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred Restricted Stock Units and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount. Read SEC document |
| May 19, 2023 Filed May 23, 2023 23:18 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 939 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-016632 · form4.xml · nonDerivative · entry 1 Drake Michael V · CIK 0001938942 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,899.7339 F1 · balance_after: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSU's may be deferred by the director, in which case payment will occur according to the elected deferral schedule. F2 · balance_after: These shares include 18 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred Restricted Stock Units and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount. Read SEC document |
| May 02, 2023 Filed May 4, 2023 00:31 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 137.7294 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-014372 · form4.xml · nonDerivative · entry 1 Drake Michael V · CIK 0001938942 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 960.7339 F1 · balance_after: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSU's may be deferred by the director, in which case payment will occur according to the elected deferral schedule. F2 · balance_after: These shares include 18 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred Restricted Stock Units and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount. Read SEC document |
| November 08, 2022 Filed Nov 11, 2022 02:14 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 171.0045 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-025332 · form4.xml · nonDerivative · entry 1 Drake Michael V · CIK 0001938942 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 810.0045 F1 · balance_after: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSU's may be deferred by the director, in which case payment will occur according to the elected deferral schedule. F2 · balance_after: These shares include five Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred Restricted Stock Units and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount. Read SEC document |
| August 09, 2022 Filed Aug 11, 2022 21:38 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 634 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-020846 · form4.xml · nonDerivative · entry 1 Drake Michael V · CIK 0001938942 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 634 F1 · balance_after: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSU's may be deferred by the director, in which case payment will occur according to the elected deferral schedule. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.